OKAY
833230
CHANGFU CO.,LTD
871396
Gansu Longshenrongfa Pharmaceutical Industry
300534
4
Tibet Duo Rui Pharmaceutical
301075
5
Chengda Pharmaceuticals
301201
(FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Money funds | -4.78%887.33M | -43.83%667.15M | -29.48%1.13B | -45.24%1.08B | -9.37%931.84M | --1.19B | 211.69%1.61B | --1.98B | 175.75%1.03B | 134.11%515.08M |
Transactional financial assets | -46.72%360.77M | 11.01%697.28M | 9.53%488.18M | --564.84M | --677.1M | --628.11M | --445.69M | ---- | ---- | ---- |
Notes receivable and accounts receivable | 47.51%168.4M | -6.63%152.6M | -70.39%53.5M | -44.07%73.48M | 13.72%114.16M | --163.43M | 21.00%180.69M | --131.37M | -74.55%100.39M | -58.12%149.32M |
-Notes receivable | 55.94%156.89M | -41.21%80.14M | -83.02%26.11M | -60.57%49.84M | 44.45%100.61M | --136.32M | 4.01%153.77M | --126.39M | -81.28%69.65M | -46.14%147.84M |
-Accounts receivable | -15.09%11.51M | 167.29%72.46M | 1.75%27.39M | 374.71%23.64M | -55.92%13.55M | --27.11M | 1,709.92%26.92M | --4.98M | 37.71%30.74M | -98.19%1.49M |
Other receivables (including interest and dividends) | 58.04%3.77M | -44.60%4.05M | 393.95%8.24M | 116.99%3.35M | 34.80%2.38M | --7.31M | -0.28%1.67M | --1.54M | -6.86%1.77M | -23.06%1.67M |
-Dividend receivable | ---- | ---- | --4.88M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Accrued interest receivable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --104.92K |
-Other receivable | 58.04%3.77M | ---- | 101.58%3.36M | ---- | 34.80%2.38M | ---- | 6.39%1.67M | ---- | -6.86%1.77M | --1.57M |
Advance payment | 34.55%5.09M | 326.34%72.19M | 490.74%73.21M | 276.99%47.9M | -52.13%3.78M | --16.93M | 99.83%12.39M | --12.71M | 96.20%7.9M | -75.13%6.2M |
Inventories | 149.86%168.96M | 61.89%93.25M | 128.42%107.05M | 16.41%76.01M | -35.84%67.62M | --57.6M | -52.07%46.87M | --65.29M | -42.58%105.39M | -39.17%97.78M |
Receivable financing | -31.15%32.52M | -55.71%9.42M | -85.70%5.63M | -8.82%38.7M | -36.02%47.24M | --21.28M | -77.35%39.37M | --42.44M | -20.83%73.83M | 87.92%173.84M |
Other current assets | 20.23%96.55M | 151.33%143.49M | 215.50%150.84M | 64.69%83.44M | 22.81%80.3M | --57.09M | -2.93%47.81M | --50.66M | 15.69%65.39M | 843.32%49.25M |
Total current assets | -10.45%1.72B | -14.02%1.84B | -15.17%2.02B | -13.63%1.97B | 39.17%1.92B | --2.14B | 139.64%2.38B | --2.28B | 24.97%1.38B | 15.20%993.15M |
Non Current assets | ||||||||||
Long-term equity investment | -0.49%274.25M | 1.38%278.76M | -38.39%276.1M | -37.46%277.33M | -48.22%275.59M | --274.96M | -46.16%448.16M | --443.45M | -31.72%532.22M | -11.54%832.45M |
Fixed assets | 32.78%877M | ---- | 120.70%627.79M | ---- | 113.79%660.47M | ---- | -3.78%284.45M | ---- | 2.72%308.93M | --295.61M |
Fixed assets liquidation | --368.75K | ---- | --368.75K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Constru in process | 76.74%641.74M | ---- | 243.55%535.38M | ---- | 246.25%363.09M | ---- | 58.71%155.84M | ---- | 45.28%104.86M | --98.19M |
Intangible assets | -0.73%2.71B | -0.96%2.72B | 16.08%2.73B | 15.94%2.73B | 16.14%2.73B | --2.74B | 29.19%2.35B | --2.35B | 793.52%2.35B | 600.16%1.82B |
Goodwill | 0.00%6.45M | 0.00%6.45M | --6.45M | --6.45M | --6.45M | --6.45M | ---- | ---- | ---- | ---- |
Long deferred expense | 107.90%104.6M | 530.25%125.83M | 1,970.55%39.48M | 3,064.27%44.16M | 8,795.21%50.31M | --19.97M | 219.79%1.91M | --1.4M | -75.50%565.63K | -58.85%596.22K |
Deferred tax assets | 98.06%55.54M | -30.20%34.74M | -22.29%29.77M | -28.25%28.01M | -29.30%28.04M | --49.76M | -8.64%38.31M | --39.04M | -12.36%39.66M | -14.74%41.94M |
Usufruct assets | 318.64%23.44M | 295.35%23.53M | --5.61M | 139.78%5.29M | 141.23%5.6M | --5.95M | ---- | --2.2M | -16.67%2.32M | -15.38%2.55M |
Other non current assets | -19.78%111.07M | 52.14%51.05M | 42.62%47.86M | 308.95%136.21M | 311.45%138.45M | --33.56M | -67.63%33.56M | --33.31M | -95.14%33.65M | 18.81%103.66M |
Total non current assets | 12.82%4.81B | 12.13%4.53B | 29.73%4.29B | 30.56%4.28B | 26.24%4.26B | --4.04B | 3.69%3.31B | --3.28B | 56.44%3.38B | 86.51%3.19B |
Total assets | 5.58%6.53B | 3.07%6.36B | 10.95%6.31B | 12.43%6.26B | 30.00%6.19B | --6.18B | 35.95%5.69B | --5.56B | 45.77%4.76B | 62.63%4.19B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Short term loan | 420.31%312.47M | 558.81%197.64M | --78.98M | --60M | --60.06M | --30M | ---- | ---- | ---- | -79.47%20.2M |
Notes payable and accounts payable | 42.33%386.63M | 61.80%327.55M | 101.09%286M | 148.15%228.29M | -68.67%271.65M | --202.44M | -83.78%142.23M | --92M | 149.78%867.09M | 168.11%876.63M |
-Notes payable | 11.29%104.91M | 64.15%107.81M | 129.02%97.36M | 217.53%95.71M | 539.01%94.27M | --65.68M | 389.89%42.51M | --30.14M | -66.10%14.75M | -23.46%8.68M |
-Accounts payable | 58.82%281.72M | 60.68%219.74M | 89.18%188.64M | 114.34%132.58M | -79.19%177.38M | --136.76M | -88.51%99.72M | --61.85M | 180.73%852.34M | 174.99%867.95M |
Contract liabilities | 22.64%34.2M | 270.68%59.07M | 584.70%59.34M | 494.03%95.86M | 8,402.17%27.88M | --15.94M | -67.53%8.67M | --16.14M | -7.76%327.96K | -44.29%26.69M |
Advance receipts | -57.28%163K | -98.92%275.03K | -57.54%207K | -40.25%285.62K | -23.98%381.54K | --25.52M | --487.54K | --478.02K | --501.92K | ---- |
Salaries payable | 30.29%49.9M | 26.46%23.98M | 26.84%21.57M | 27.19%26.4M | 73.33%38.3M | --18.96M | -7.72%17.01M | --20.75M | -25.47%22.1M | -8.89%18.43M |
Taxs payable | -60.96%6.69M | 124.51%23.23M | 23.18%24.63M | 110.78%28.66M | 287.88%17.14M | --10.35M | -3.17%20M | --13.6M | 131.56%4.42M | -50.10%20.65M |
Other payable (including interest and dividends) | 11.74%262.24M | 34.07%257.5M | -0.12%278.75M | 45.87%259.09M | 31.83%234.7M | --192.06M | 8.30%279.08M | --177.62M | 130.18%178.03M | 244.45%257.7M |
-Interest payable | ---- | ---- | ---- | ---- | ---- | --166.67K | 91.96%447.9K | --277.25K | 93.81%497.44K | --233.33K |
-Dividend payable | ---- | ---- | -87.50%12.8M | ---- | ---- | ---- | --102.4M | ---- | ---- | ---- |
-Other payable | 11.74%262.24M | ---- | 50.91%265.95M | ---- | 32.20%234.7M | ---- | -31.55%176.23M | ---- | 130.30%177.54M | --257.47M |
Non current liabilities due within one year | -4.22%231M | -7.00%181M | -47.78%191.14M | -52.86%191.18M | -33.72%241.19M | --194.62M | 343.10%365.99M | --405.52M | 502.27%363.91M | 19,385.32%82.6M |
Other current liabilities | 172.71%54.61M | -29.00%32.8M | -53.28%17.9M | 74.92%23.55M | -9.70%20.02M | --46.2M | -56.80%38.32M | --13.46M | -81.63%22.17M | 12.67%88.71M |
Total current liabilities | 46.81%1.34B | 49.85%1.1B | 9.95%958.52M | 23.49%913.31M | -37.52%911.32M | --736.08M | -37.35%871.78M | --739.57M | 84.19%1.46B | 102.02%1.39B |
Current liabilities | ||||||||||
Long term loan | -47.35%100.04M | ---- | -21.78%185M | -30.30%185M | -27.18%190M | --190M | 24.48%236.51M | --265.41M | 37.32%260.91M | --190M |
Long term account payable | -14.90%1.03B | ---- | -0.42%1.21B | ---- | 122.75%1.21B | ---- | --1.21B | ---- | 116.57%541.43M | ---- |
Estimate liabilities | 64.99%122.35M | 16.06%76.49M | 168.67%75.71M | 113.23%74.46M | 111.26%74.16M | --65.91M | -33.51%28.18M | --34.92M | -19.38%35.1M | -18.09%42.39M |
Deferred tax liabilities | 10.31%48.69M | 5.38%45.41M | 1,311.28%42.03M | 1,335.49%43.29M | 1,127.72%44.14M | --43.09M | -2.88%2.98M | --3.02M | 15.48%3.6M | -26.36%3.07M |
Long term deferred income | 4.58%7.81M | -24.15%6.2M | -29.23%6.16M | -23.09%6.8M | -24.56%7.47M | --8.17M | --8.71M | --8.84M | --9.9M | ---- |
Lease liabilities | 379.60%20.71M | 227.90%20.09M | --3.65M | 75.39%3.47M | 120.97%4.32M | --6.13M | ---- | --1.98M | -18.86%1.95M | -26.18%2.13M |
Total non current liabilities | -13.11%1.33B | -21.45%1.35B | 2.09%1.52B | -0.41%1.52B | 78.94%1.53B | --1.72B | 123.87%1.49B | --1.53B | 74.39%852.89M | 1,029.36%664.46M |
Total liabilities | 9.29%2.66B | -0.11%2.46B | 4.99%2.48B | 7.40%2.43B | 5.45%2.44B | --2.46B | 14.75%2.36B | --2.26B | 80.45%2.31B | 174.99%2.06B |
Shareholders equity | ||||||||||
Paid-in capital | 0.00%800M | 0.00%800M | 0.00%800M | 0.00%800M | 33.33%800M | --800M | 33.33%800M | --800M | 0.00%600M | 0.00%600M |
Capital reserve funds | -0.15%1.36B | 0.00%1.36B | 0.00%1.36B | 0.00%1.36B | 82.57%1.36B | --1.36B | 90.42%1.36B | --1.36B | 4.30%744.12M | -0.00%713.45M |
Surplus reserve funds | 3.92%113.15M | 8.47%108.88M | 8.47%108.88M | 8.47%108.88M | 8.47%108.88M | --100.38M | 9.59%100.38M | --100.38M | 9.59%100.38M | 23.61%91.59M |
Retained profit | 0.71%752.27M | 5.89%783.94M | 18.91%756.21M | 12.06%787.28M | 11.28%746.96M | --740.37M | 4.88%635.96M | --702.53M | 39.87%671.25M | 63.41%606.36M |
Specific reserves | -18.22%24.01M | 13.75%33.26M | 292.08%34.5M | 166.06%32.28M | 150.97%29.36M | --29.24M | -33.50%8.8M | --12.13M | -6.33%11.7M | 5.75%13.23M |
Shareholders equity without minority interests | 0.07%3.05B | 1.85%3.08B | 5.32%3.06B | 3.81%3.09B | 43.07%3.04B | --3.03B | 43.42%2.9B | --2.97B | 12.12%2.13B | 14.31%2.02B |
Minority interests | 16.57%821.38M | 19.83%822.75M | 82.07%778.42M | 126.41%735.78M | 120.49%704.61M | --686.58M | 306.52%427.54M | --324.98M | 271.89%319.56M | 90.84%105.17M |
Total shareholder equity | 3.17%3.87B | 5.18%3.91B | 15.17%3.84B | 15.89%3.82B | 53.18%3.75B | --3.72B | 56.41%3.33B | --3.3B | 23.38%2.45B | 16.62%2.13B |
Total liabilityies and equity | 5.58%6.53B | 3.07%6.36B | 10.95%6.31B | 12.43%6.26B | 30.00%6.19B | --6.18B | 35.95%5.69B | --5.56B | 45.77%4.76B | 62.63%4.19B |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
Auditor | Daxin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.